Publication | Open Access
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
47
Citations
24
References
2025
Year
F Hoffmann-La Roche and Genentech.
| Year | Citations | |
|---|---|---|
Page 1
Page 1